Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA).

@article{Ampadu2018SafetyED,
  title={Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA).},
  author={Haggar H. Ampadu and Alexander N. O. Dodoo and Samuel Bosomprah and Samantha Akakpo and Pierre Hugo and H Gardarsdottir and Hubert G. M. Leufkens and Dan Kajungu and Kwaku Poku Asante},
  journal={Drug safety},
  year={2018},
  volume={41 9},
  pages={
          871-880
        }
}
INTRODUCTION Injectable artesunate (Inj AS) is the World Health Organization (WHO)-recommended product for treating severe malaria. However, despite widespread usage, there are few published safety studies involving large populations in real-world settings. In this study, we sought to assess the incidence of common adverse events (AEs) following the intake… CONTINUE READING